while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.http://lm360.us/Jozwiak-daughter-of-Barbeau-from-Bonshaw?Arenivars=249
.i just called to see how you guys are doing. give us a call � i hope you're having a good time, wherever you are.
.